Psiguadial D exhibits significant antimicrobial activity, making it a candidate for development in anti-infective agents. It has shown inhibitory effects against several Gram-positive bacterial strains, which suggests potential use in treating bacterial infections resistant to conventional antibiotics. Additionally, its unique dimeric structure contributes to cytotoxic properties observed in certain cancer cell lines, indicating possible application in oncology for targeted therapies. Research also explores its role as a biochemical tool for studying cellular pathways involving oxidative stress and apoptosis. Due to its natural origin and specific bioactivity, Psiguadial D is of interest in the design of novel pharmaceuticals and as a lead compound in drug discovery programs.